- Home
- NL vs CTNM Comparison
NL vs CTNM Comparison
Compare NL & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- CTNM
- Stock Information
- Founded
- NL 1891
- CTNM 2009
- Country
- NL United States
- CTNM United States
- Employees
- NL N/A
- CTNM N/A
- Industry
- NL Major Chemicals
- CTNM
- Sector
- NL Industrials
- CTNM
- Exchange
- NL Nasdaq
- CTNM Nasdaq
- Market Cap
- NL 286.8M
- CTNM 248.7M
- IPO Year
- NL N/A
- CTNM 2024
- Fundamental
- Price
- NL $6.02
- CTNM $11.29
- Analyst Decision
- NL
- CTNM Strong Buy
- Analyst Count
- NL 0
- CTNM 5
- Target Price
- NL N/A
- CTNM $22.20
- AVG Volume (30 Days)
- NL 27.6K
- CTNM 210.9K
- Earning Date
- NL 11-05-2025
- CTNM 11-05-2025
- Dividend Yield
- NL 5.96%
- CTNM N/A
- EPS Growth
- NL 141.37
- CTNM N/A
- EPS
- NL 1.10
- CTNM N/A
- Revenue
- NL $152,721,000.00
- CTNM N/A
- Revenue This Year
- NL $15.75
- CTNM N/A
- Revenue Next Year
- NL $2.44
- CTNM N/A
- P/E Ratio
- NL $5.60
- CTNM N/A
- Revenue Growth
- NL N/A
- CTNM N/A
- 52 Week Low
- NL $5.29
- CTNM $3.35
- 52 Week High
- NL $9.42
- CTNM $20.24
- Technical
- Relative Strength Index (RSI)
- NL 45.26
- CTNM 55.29
- Support Level
- NL $5.81
- CTNM $10.65
- Resistance Level
- NL $6.35
- CTNM $12.14
- Average True Range (ATR)
- NL 0.24
- CTNM 0.97
- MACD
- NL -0.00
- CTNM -0.23
- Stochastic Oscillator
- NL 38.89
- CTNM 31.27
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.